Newmont Valuation
Is NEM * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NEM * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NEM * (MX$724.36) is trading above our estimate of fair value (MX$646.69)
Significantly Below Fair Value: NEM * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NEM *?
Other financial metrics that can be useful for relative valuation.
What is NEM *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$49.27b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.3x |
Enterprise Value/EBITDA | 15.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NEM *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.7x | ||
GMEXICO B Grupo México. de | 3.5x | 6.1% | Mex$830.7b |
PE&OLES * Industrias Peñoles. de | 1.1x | -0.08% | Mex$114.7b |
CEMEX CPO CEMEX. de | 0.7x | 3.3% | Mex$204.9b |
ICH B Industrias CH S. A. B. de C. V | 1.5x | n/a | Mex$75.4b |
NEM * Newmont | 3.7x | 8.3% | Mex$49.3b |
Price-To-Sales vs Peers: NEM * is expensive based on its Price-To-Sales Ratio (3.7x) compared to the peer average (1.7x).
Price to Earnings Ratio vs Industry
How does NEM *'s PE Ratio compare vs other companies in the South American Metals and Mining Industry?
Price-To-Sales vs Industry: NEM * is expensive based on its Price-To-Sales Ratio (3.7x) compared to the South American Metals and Mining industry average (0.6x).
Price to Sales Ratio vs Fair Ratio
What is NEM *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 3.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NEM *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$724.36 | Mex$799.27 +10.3% | 9.7% | Mex$960.21 | Mex$656.54 | n/a | 21 |
Apr ’25 | Mex$607.75 | Mex$748.30 +23.1% | 14.7% | Mex$993.85 | Mex$551.75 | n/a | 21 |
Mar ’25 | Mex$540.00 | Mex$792.24 +46.7% | 13.3% | Mex$1,025.89 | Mex$615.54 | n/a | 20 |
Feb ’25 | Mex$610.00 | Mex$838.35 +37.4% | 11.4% | Mex$1,025.19 | Mex$666.37 | n/a | 20 |
Jan ’25 | n/a | Mex$840.72 0% | 13.7% | Mex$1,052.90 | Mex$652.29 | n/a | 20 |
Dec ’24 | Mex$695.50 | Mex$849.60 +22.2% | 13.1% | Mex$1,031.82 | Mex$660.54 | n/a | 19 |
Nov ’24 | Mex$678.00 | Mex$899.48 +32.7% | 13.1% | Mex$1,083.21 | Mex$686.03 | n/a | 18 |
Oct ’24 | Mex$663.99 | Mex$929.27 +40.0% | 11.0% | Mex$1,098.15 | Mex$732.10 | n/a | 18 |
Sep ’24 | Mex$650.00 | Mex$907.37 +39.6% | 11.2% | Mex$1,057.98 | Mex$705.32 | n/a | 19 |
Aug ’24 | Mex$716.00 | Mex$928.07 +29.6% | 8.9% | Mex$1,060.21 | Mex$740.46 | n/a | 20 |
Jul ’24 | Mex$724.50 | Mex$980.35 +35.3% | 11.0% | Mex$1,147.01 | Mex$750.01 | n/a | 21 |
Jun ’24 | Mex$750.00 | Mex$1,016.98 +35.6% | 10.8% | Mex$1,185.12 | Mex$753.88 | n/a | 21 |
May ’24 | Mex$849.66 | Mex$1,026.03 +20.8% | 10.3% | Mex$1,204.65 | Mex$768.82 | n/a | 21 |
Apr ’24 | Mex$881.43 | Mex$1,024.06 +16.2% | 9.5% | Mex$1,266.94 | Mex$868.76 | Mex$607.75 | 20 |
Mar ’24 | Mex$800.42 | Mex$1,043.40 +30.4% | 8.1% | Mex$1,286.33 | Mex$918.81 | Mex$540.00 | 20 |
Feb ’24 | Mex$1,000.00 | Mex$1,053.71 +5.4% | 7.6% | Mex$1,205.09 | Mex$866.16 | Mex$610.00 | 19 |
Jan ’24 | Mex$928.25 | Mex$1,044.23 +12.5% | 11.5% | Mex$1,256.90 | Mex$765.92 | n/a | 19 |
Dec ’23 | Mex$935.00 | Mex$1,022.21 +9.3% | 11.8% | Mex$1,234.57 | Mex$752.31 | Mex$695.50 | 18 |
Nov ’23 | Mex$822.50 | Mex$1,087.36 +32.2% | 16.5% | Mex$1,568.13 | Mex$769.08 | Mex$678.00 | 18 |
Oct ’23 | Mex$850.00 | Mex$1,235.91 +45.4% | 21.1% | Mex$2,012.30 | Mex$845.17 | Mex$663.99 | 18 |
Sep ’23 | Mex$859.00 | Mex$1,309.52 +52.4% | 19.6% | Mex$2,011.88 | Mex$925.46 | Mex$650.00 | 17 |
Aug ’23 | Mex$931.00 | Mex$1,367.22 +46.9% | 18.2% | Mex$2,046.88 | Mex$1,064.38 | Mex$716.00 | 17 |
Jul ’23 | Mex$1,193.00 | Mex$1,586.01 +32.9% | 12.7% | Mex$1,993.48 | Mex$1,076.48 | Mex$724.50 | 17 |
Jun ’23 | Mex$1,356.95 | Mex$1,588.29 +17.0% | 12.6% | Mex$1,991.92 | Mex$1,075.64 | Mex$750.00 | 17 |
May ’23 | Mex$1,493.00 | Mex$1,628.84 +9.1% | 12.1% | Mex$2,019.72 | Mex$1,151.24 | Mex$849.66 | 17 |
Apr ’23 | Mex$1,634.00 | Mex$1,388.08 -15.0% | 9.7% | Mex$1,635.66 | Mex$1,156.93 | Mex$881.43 | 17 |
Analyst Forecast: Target price is less than 20% higher than the current share price.